
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Sample: What tobacco product was most commonly used among US adults in 2018? E-cigarettes? Traditional cigarettes? Neither? The answer may surprise.






